Multiple alleles at the kelch13 locus conferring artemisinin resistance (ART-R) are currently spreading through malaria parasite populations in Southeast Asia, providing a unique opportunity to directly observe an ongoing soft selective sweep, to investigate why resistance alleles have evolved multiple times and to determine fundamental population genetic parameters for Plasmodium. We sequenced the kelch13 gene (n=1,876), genotyped 75 flanking SNPs, and measured clearance rate (n=3,552) in parasite infections from Western Thailand (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014). We describe 32 independent coding mutations: these included common mutations outside the kelch13 propeller region associated with significant reductions in clearance rate. Mutations were first observed in 2003 and rose to 90% by 2014, consistent with a selection coefficient of ~0.079. There was no change in diversity in flanking markers, but resistance allele diversity rose until 2012 and then dropped as one allele (C580Y) spread to high frequency. The rapid spread of C580Y suggests that the genomic signature may be considerably harder in the near future, and that retrospective studies may underestimate the complexity of selective sweeps. The frequency with which adaptive alleles arise is determined by the rate of mutation to generate beneficial alleles and the population size. Two factors drive this soft sweep: (1) multiple amino-acid mutations in kelch13 can confer resistance providing a large mutational target -we estimate the target size is between 87 and 163bp. (2) The population mutation parameter (Θ=2N e μ) can be estimated from the frequency distribution of resistant alleles and is ~ 5.69, suggesting that short term effective population size is between 88 thousand and 1.2 million. This is 52 to 705-fold greater than N e estimates based on fluctuation in allele frequencies, suggesting that we have previously underestimated the capacity for adaptive evolution in Plasmodium. Our central conclusions are that retrospective studies may underestimate the complexity of selective events, ART-R evolution is not limited by availability of mutations, and the N e relevant for adaptation for malaria is considerably higher than previously estimated.
INTRODUCTION
The number of times drug resistance alleles arise is a central question for disease intervention because it determines the useful life of drugs, the ease with which resistance arises, and the utility of diagnostic markers for tracking resistance. It is also a question of central interest for evolutionary biologists interested in adaptation, where the relative role of hard selective events, in which flanking genetic variation is purged from around the selected site, and soft selective events in which flanking genetic variation is maintained, is being actively debated (1, 2) . The frequency with which beneficial alleles establish is expected to be determined by the rate (μ) at which mutations conferring resistance are introduced into the population (by mutation or migration) and the effective size (N e ) of the population during the time when selection is acting: these parameters are combined in the population mutation parameter (Θ = 2N e μ). Elegant theoretical work (3, 4) has led to the prediction that when Θ<0.01, mutations will be limiting and most selective events will involve single alleles generating hard selective sweeps, when Θ is between 0.01 and 1 both single and multiple origins of adaptive alleles are possible, and when Θ > 1, multiple origins of adaptive alleles are expected.
Most studies of selection in nature are retrospective, so the underlying dynamics of these events are incompletely understood. Typically, genetic data from present day populations is used to infer selective events that have occurred in the past. The surge of recent next generation sequencing studies has generated large genomic datasets from multiple organisms and haplotype tests for detecting signatures of past selection have been widely used to catalogue selected genome regions.
However, these methods can only detect the "fossil record" of selection in the genome. While valuable, this genomic fossil record may provide a simplified description of adaptive evolution, which is biased because only surviving allelic lineages are examined. In contrast, molecular description of ongoing adaptive evolution in nature provides a direct record of the dynamics of selective events, including documentation of allelic lineages that fail to survive. Molecular dissection of rapid evolution of microbial or insect populations in the face of ongoing selection with drugs of pesticides are particularly valuable in this respect (5) (6) (7) (8) .
Malaria parasites provide a powerful system for studying adaptation in nature, because parasite populations have been exposed to a succession of antimalarial compounds over the past 75 years, and selection is strong, with coefficients of 0.1-0.4 recorded (9) . Parasite genomes are compact (23Mb), blood stage parasites are haploid, and there is an obligate recombination in the mosquito stage, making this a useful system for understanding adaptation in other recombining eukaryotes.
Retrospective molecular studies of resistance to chloroquine and pyrimethamine, in which variation at markers flanking resistance mutations were examined, have revealed remarkably few independent origins of resistance alleles (10) (11) (12) . Selection appears to have driven textbook "hard" selective sweeps, in which single resistance haplotypes have rapidly spread through malaria parasite populations purging genetic variation in the vicinity of the resistance locus and spreading across global parasite populations. The rarity of independent resistance alleles is surprising given that each infected human contains up to ~10 11 parasites, so we would expect that each infected person will contain 10-100 parasites with mutations at each position in the genome assuming standard eukaryotic SNP mutation rates. However, the rarity of mutations is consistent with measures of short-term N e , determined from temporal fluctuation in allele frequencies: these genetic-drift based N e estimates range from under one hundred (13) to several thousand (14) . However, these studies of chloroquine and pyrimethamine resistance were retrospective (15) because they examined parasite population samples collected ~25 years after the origins of resistant parasites in the 1950-70s. Hence we were unable to precisely document these selective events as they were occurring.
The recent discovery of a major ART-R gene, kelch13, in SE Asia, in which resistance alleles clearly have multiple independent origins (16) (17) (18) , supports a radically different model of resistance evolution, and provides a unique opportunity to examine an ongoing selective event in a recombining eukaryote and to estimate key population parameters for Plasmodium. Transfection experiments unambiguously demonstrate that single amino acid edits in kelch13 increase survival of cultured parasites (19) ,
showing that this gene alone is sufficient to cause ART-R. ART-R was first confirmed in SE Asia in 2009 (17) . ART-R parasites show 100-1,000 fold slower clearance than sensitive parasites over a single 48 hour parasite life-cycle, and this results in increased treatment failure rates (20) (21) (22) . Here, we describe the spread of resistance alleles in a longitudinal collection of parasites from the ThailandMyanmar border between 2001 and 2014. Thirty-two independent mutations have spread through this parasite population generating an extraordinarily soft selective event. However, haplotypes associated with one particular mutation now dominate this parasite population, so the dynamics of this sweep are soft, but the signature in several years time is expected to be that of a much harder sweep. We use these data to estimate critical parameters such as the population mutation rate (3, 4) and the short term effective population size (N e ) for malaria and more generally to ask why there should be so many independent origins of ART-R.
MATERIALS AND METHODS

Study site and patients
We collected P. falciparum infected blood samples from patients visiting malaria clinics run by the Shoklo Malaria Research Unit (SMRU) which span a 150 km region of the North-Western border of Thailand between 2001 and 2014. The blood samples collected were finger prick blood spots (~30μl whole blood dried on Whatmann 3M filter paper) or venous blood samples depleted of white blood cells (23) . The four clinics sampled, which span ~100km along the western border of Thailand, were Maela (refugee camp) and Wang Pha village to the north of Maesot, and Mae Kon Khen and Mawker
Thai villages to the south of Maesot. The majority of patients came from adjacent Myanmar.
Falciparum malaria was diagnosed by microscopy of thick and thin peripheral blood smears stained with Giemsa. Parasite counts were read per 1,000 red cells (thin film) or 500 white cells (thick film).
The parasite samples included in this study came from three different groups of patients: (a)
Uncomplicated hyperparasitaemia patients with ≥4% of red cells infected. These patients were treated with artesunate (ART) alone followed by combination therapy as described previously (24) . Following treatment, we monitored parasite clearance by measuring parasite density in the blood at 6 hourly intervals until the patient became slide negative. These data were used to measure parasite clearance rates (see below 
Measurement of parasite clearance half-life
Slow parasite clearance from the bloodstream of infected patients is a hallmark of ART-R (26) and was determined in all hyperparasitaemia patients. We measured the rate of parasite clearance by plotting log parasite density against time using a standardized fitting method which separates the variable initial lag-phase from the subsequent log-linear decline (27) using the online parasite clearance calculator (http://www.wwarn.org/tools-resources/toolkit/analyse/parasite-clearanceestimator-pce). We measured the slope of the linear phase and determined the parasite clearance half life (T 1/2 P), defined as the time required for parasitaemia to fall by half during the log-linear decline. We excluded parasite clearance curves showing a poor fit (r 2 < 0.8) to the log-linear model.
Genotyping of parasites
We extracted DNA admission blood spots using a two step protocol to maximize DNA yield. Blood was eluted from the six three mm punches using the Gensolve kit (GenVault Corporation) and DNA extracted using 96-well QIAamp 96 DNA Blood Kits (Qiagen). Whole blood samples were extracted using the Gentra PureGene kit (QIAGEN) and DNA concentration was quantified using a Qubit fluorometer.
We genotyped parasite infections from hyperparasitemic patients using 96-SNPs distributed across the P. falciparum genome using the Illumina Veracode platform. We considered infections to contain multiple clones if >5 SNPs showed heterozygous base calls (14) . We used single clone infections for subsequent molecular analyses, because haplotypes can be unambiguously constructed.
To further assess haplotype structure around the kelch13 locus, we genotyped an additional 163
SNPs using Goldengate from a subset of samples (genetically unique single clone infections from the hyperparasitemia study, and all samples from the treatment efficacy study). The 163 SNPs comprised included 75 SNPs on chr 13 as well as 88 SNPs on other chromosomes. The SNPs genotyped were located in genome regions showing association with ART-R in previous association (28) and pooled sequencing studies (29) , so are not randomly ascertained.
Sequencing of kelch13 locus
We amplified three PCR fragments from the kelch13 locus and sequenced products in both directions and sequenced them directly in both directions using the BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems, Inc., Foster City, CA). We cleaned BigDye products using the BigDye XTerminator Purification kit (Applied Biosystems, Inc.) and ran them on an ABI 3730 capillary sequencer. We aligned and analyzed data using SeqScape version 2.7. We excluded parasite samples with incomplete sequence data for one or more fragments from the analysis.
Analysis
All analyses were conducted using R version 3.2.3.
Selection coefficients -We measured selection coefficients for kelch13 mutations by plotting log(R/S) over time and measuring the slope. Time was measured in Plasmodium generations (the time taken for parasites to traverse both mosquito and human stages of the lifecycle). The length of a Plasmodium generation varies and is dependent on multiple factors such as gametocyte production and vector abundance. We used generation times of 1.5, 2 and 3 months.
Modeling the selective sweep -Whether selective sweeps are soft or hard is critically dependent on the rate at which beneficial mutations are introduced into the population, which is determined by the population size over the time period in which selection is acting, and the rate at which beneficial mutations are generated. We used published theory (3, 4) to examine the fit of our data to predictions for soft selective sweeps. The critical parameter determining whether soft selective sweeps will occur is the population mutation parameter (Θ=2N e μt ), where N e is the effective population size during the time period in which adaptation occurs (here between 1995 when ART treatment was first introduced and the present time where resistance alleles are close to fixation), μ is the per nucleotide mutation rate per Plasmodium generation (the complete lifecycle from including mosquito and human development), and t (the mutational "target" size) defined as the number of nucleotides at which mutations can generate a resistance phenotype.
Θ can be determined directly from the numbers of independent origins of resistance mutations in kelch13 in our population sample using eqn. 12 in Pennings and Hermisson (3):
Stirling's number of the first kind, n is the sample size and k is the number of haplotypes observed. We determined 95% confidence intervals from the Pr( | , ) probability distribution across a range of Θ values. Since Θ=2N e μt, we estimated N e using measures of mutation rate (μ) and target
The mutation rate (μ) has been measured in two mutation accumulation experiments (30, 31) . These estimates range from 1.7-3.2 x 10 -9 (31) to 3.82-4.28 x 10 -10 per base/48hr asexual cycle (30) . The estimates are mutation rates for a single 48 hour asexual parasite cycle. We use the mean mutation rate (3.39 x10 -9 , range: 1.7-4.28 x10 -9 ) and converted per cycle rates to per generation mutation rates by multiplying by g/2, where g is the length in days of a malaria parasite generation (the duration of the complete parasite lifecycle, from mosquito to mosquito), and 2 days is the length of a single asexual cycle. We use a two month generation time per year so g=~60 days. We have assumed that the rate of cell division is the same in mosquito and human sections of the parasite lifecycle.
We estimated the mutational target size (t) -the number of bases at which mutations can generate ART-R -by counting the numbers of different mutations associated with ART-R in this study and in other recent papers describing sequence variation in kelch13. We then used rarefaction approaches (32) to estimate the number of possible resistance alleles, from the rate at which new alleles are discovered.
Genotype-phenotype associations -We compared clearance half life (T 1/2 P) of parasites bearing kelch13 mutations compared with wild-type alleles using t-tests. We used uncorrected tests to avoid needless rejection of the null hypothesis (i.e. no difference in T 1/2 P) due to low sample size (8 mutations are found in ≤3 samples), and because the vast majority of mutations are expected to differ in phenotype from WT. In addition, we examined pair wise differences in T 1/2 P between different kelch13 alleles to determine allele specific variation in clearance: in this case Bonferroni correction was used.
SNP variation on chromosome 13 -We measured extended haplotype homozygosity (EHH) using rehh (33) to examine hitchhiking associated with different kelch13 alleles. We computed SNP-π for each bi-allelic SNP: this is defined as the average proportion of pairwise differences at assayed SNP loci within a defined population (34) . Average SNP-π across SNPs was then computed for SNPs flanking kelch13 to investigate changes in genetic variation over time. We measured expected heterozygosity (H e ) at the kelch13 locus by treating kelch13 as a single locus with multiple alleles. To evaluate evidence for independent origins of particular ART-R mutations, we used poppr (35) with default settings to construct minimum spanning networks comparing the relationships between different SNP haplotypes for the chr. 13 region surrounding kelch13. This analysis used chr. 13 data with ≤5 missing SNPs or ambiguous base calls.
RESULTS
Dataset
We collected parasite genotypes, kelch13 sequence and/or parasite clearance data from 4,867 shows how these patient samples were used for different analyses. After removing data whose clearance rate curve fitted poorly to a linear model (r 2 ≥0.8) 3,552 remained. We excluded multiple clone infections by genotyping a panel of 93 variable SNPs (24) in the hyperparasitemia samples. We determined sequence at the kelch13 locus in 1,876 infections. In addition, to examine the impact of kelch13 on flanking variation we genotyped an additional 163 SNPs (75 on chr. 13, and 88 elsewhere in the genome) in a subset of samples.
Change in parasite clearance rate
We previously described the change in clearance rate from 2001-2010 (24) . Mean T 1/2 P accelerates during 2011-14, reaching over 6.0hrs in 2014 (Fig. 1A) . The dynamics of CR increase differ between locations (Fig. S2) .
Mutations in the kelch13 locus
We observed 32 independent non-synonymous mutations in the kelch13 locus. (Fig. 1B) . The rise in kelch13 allele frequency closely tracks change in parasite T 1/2 P over time in the 4 clinics examined (Fig. 1A and B, S2 and S3) and we see parallel changes in both hyperparasitemia and efficacy study data sets (Fig. S4) . The most abundant allele before 2008 was E252Q (Fig. 1B and D) . C580Y allele was first observed in 2006, reached 4% frequency in 2010, and by 2014 reached 65% (Fig. 1B and D) (72% of resistant alleles) and was at fixation or close to fixation in all clinics except for MLA (Fig. S3 ).
Only two other alleles reached over 10% allele frequency (E252Q in 2007 and 2009-12, and R561H in 2012) during the 14 year sampling period.
We determined selection coefficients driving kelch13 mutations ( (Fig. 1E ).
Genotype-phenotype associations
We compared T 1/2 P in parasite infections carrying different kelch13 alleles (n=1,044, ). C580Y (T 1/2 P = 6.35) parasites cleared faster than several other kelch13 common ART-R alleles (R561H (T 1/2 P = 7.00) and N458Y (T 1/2 P = 7.12)), although these differences were not significant after correction for multiple testing (Fig. 2B ).
Whether additional loci in the genome impact clearance rates is an open question. We examined whether clonally indistinguishable groups of parasites isolated from different patients, but bearing the same mutation showed significant heterogeneity in T 1/2 P for common genotypes including WT, E252Q, and C580Y. Among the 612 WT parasites there were 88 groups of unique WT genotypes infecting 2-13 patients, but we observed no evidence for heterogeneity in T 1/2 P (F=0.0373, df=1, ns).
Similarly for C580Y (n=99, 15 groups infecting 2-6 patients, F=0.031, df=1, ns) and E252Q (n=100, 18 groups infecting 2-10 patients, F=1.1275, df=1, ns) we found no evidence for genetic background effects influencing T 1/2 P (Table S1 ).
Linkage disequilibrium and hitchhiking around kelch13
Soft sweeps are expected to have much less impact on flanking diversity than hard sweeps, because multiple background haplotypes hitchhike with selected mutations. We measured SNP diversity (SNP-π) surrounding WT and alleles associated with elevated clearance rate for 2008-13. We observed no difference in diversity between parasites carrying WT and kelch13 ART-R alleles on any year examined (Fig. 3A) . However, when we examined SNP-π for SNPs surrounding individual kelch13
SNPs alleles we observed significant reduction in diversity relative to WT parasites for all common SNP alleles except M461I and E252Q (Fig. 3B) . This was also reflected in increased linkage disequilibrium surrounding kelch13 ART-R alleles (Fig. 3C-D, Fig. S5 ). We inspected the length of haplotypes surrounding individual kelch13 alleles from the decay in expected haplotype homozygosity (EHH), defining elevated EHH as above 0.2. All common alleles examined showed elevated EHH (432-2,130kb) relative to WT alleles (182kb) (Fig. 3D) . Two particular alleles showed extremely long tracts of high EHH (G538V: 2446kb; P441L: 2130kb). E252Q has the shortest region of elevated EHH (432kb), but there was no relationship between the impact of alleles on clearance rate, and the length of LD observed. Furthermore, C580Y, which is increasing in frequency rapidly in this and other SE Asian populations, showed moderate levels of LD.
Multiple origins of individual resistance mutations
Kelch13 resistance alleles with different amino acid mutations clearly demonstrate independent origins of artemisinin resistance. However, it is also possible that particular amino acid mutations at kelch13 have arisen more than once: such independent alleles are expected to have different flanking SNP haplotypes. We used minimum spanning networks to examine the relationships between haplotypes surrounding different ART-R alleles to evaluate the evidence for multiple origins of particular amino acid mutations (Fig. S6) . These analyses focused on the 33 SNPs immediately flanking kelch13 in a 472kb region (1459805-1931812bp) (see Fig. S5 ). Three ART-R SNPs (C580Y, N458Y, and R561H) are found on divergent genotypes, suggesting 2-4 independent origins of each codon change. E252Q haplotypes are widely distributed across the minimum spanning networks.
E252 haplotypes also show limited LD (Fig. 3A) ; for this ART-R SNP distinguishing between multiple origins and recombination is problematic.
Estimation of the mutational target size
The mutation target size (t) can be directly estimated from the number of mutations observed in kelch13 that alter parasite clearance rate. We observe 32 different non-synonymous mutations in this 
Estimation of population mutation parameter
We estimated the Θ (Pr Θ) given the observed numbers of independent ART-R alleles in population samples from 2008-14 ( Table S3 ). Note that these are lower bounds, because we have not accounted for resistance alleles that have arisen more than once.
DISCUSSION
Mutations outside the propeller domain are associated with slow clearance
The current molecular screening approach for ART-R involves sequencing the propeller region of kelch13 (1,725,980-1,726,940bp, amino acid positions 419-707) as this is where non-synonymous mutations associated with slow clearance rate were originally discovered in Cambodian parasite populations (40) . On the Thailand-Myanmar border, the most common mutation observed prior to 2011 was E252Q. This mutation is situated 167 amino acids 5' of the propeller region and is associated with significantly slower clearance than WT parasites, as well as significantly elevated treatment failure rates (22) . Furthermore, two other mutations (D281V and R239Q) close by are also associated with slow clearance rate, arguing that molecular surveillance for resistance should be expanded outside the kelch13 propeller domain. Furthermore, these mutations outside the propeller region may also provide valuable clues as to which sections of kelch13 are involved in molecular interactions with other P. falciparum proteins. Whether these mutations are causative or linked to nearby non-coding changes associated with slow clearance is currently unclear.
Of 25 non-synonymous mutations for which accompanying clearance rate data was available, 23/25 (92%) were associated with slower clearance than WT parasites: the vast majority of mutations in this conserved gene influence phenotype. However, mutations differed significantly in associated clearance rate. E252Q shows slower clearance than WT alleles, but significantly faster clearance than the majority of propeller mutations including C580Y. Alleles also show heterogeneity in their impact on treatment failure (22) , which should be directly linked to their capacity to spread. Phenotypic heterogeneity among alleles suggests that ART-R mutations in kelch13 cause partial rather than complete loss of function. C580Y is of special interest as this allele is spreading to fixation in this population, and other studied SE Asian parasite populations (16, 40) . C580Y is associated with faster clearance rate than two other mutations (R561H and N458Y). However, this difference is not significant after correction for multiple testing. The success of this allele may stem from the fact that the structural changes result from internal disruption of a disulphide bond, rather than changes in size or charge of amino acids exposed on the kelch13 surface.
One explanation for heterogeneity in clearance rate might be involvement of other loci in the genome. Diminishing complexity of selective events at dihydrofolate reductase (dhfr) is also observed during evolution of pyrimethamine resistance in both Africa and Asia. For example, on the Thai-Myanmar border, there were several independent origins of S108N mutation, which is the first step of resistance evolution (10) . However, high level resistance involving N51I, C59R and I164L was only associated with a single chr. 4 haplotype. Similarly, in Africa, there were multiple origins of parasites containing a single mutation (S108N), three separate origins of parasites carrying double mutant (N51I/S108N or C59R/S108N) (45), but these have been rapidly replaced by triple mutant parasites originating in Asia (11) .
Both kelch13 and dhfr datasets support a model in which selection events are soft initially, but rapidly become harder, as particular alleles dominate. Continuing surveillance of the parasite population on the Thai-Myanmar border will determine whether this trend continues and eventually leaves a single resistance kelch13 mutation and a hard signature. Most theoretical work assumes that beneficial alleles selected during soft selective sweeps are functionally equivalent, and therefore whether particular beneficial mutations fix is dependent on genetic drift rather than selection (3). Demographic alone can result in loss of adaptive alleles (46) . However, in the malaria examples, differences in the selection coefficients of resistance alleles are most likely responsible for the hardening of the sweep.
Kelch13 alleles are not functionally equivalent and differ in both clearance and ability to survive treatment (22) . That independent C580Y alleles have spread to high frequency in different countries in SE Asia also suggests that this allele has higher fitness than other ART-R alleles. More generally, we suggest that retrospective studies of sequence variation in extant populations are likely to underestimate the frequency and complexity of soft selective events.
An interesting feature of these data is that multiple alleles showing moderate fitness benefit initially spread in this population. For example the E252Q allele is associated with a modest change in clearance rate, and a modest impact on surviving ART-treatment relative to other ART-alleles. C580Y
out competes other alleles after 2011. These data are consistent with both theoretical and empirical work on adaptation demonstrating that the distribution of fitness effects of beneficial mutations is exponential: while multiple mutations can generate phenotypes with modest increase in fitness, only a small subset of mutations show high fitness (47, 48) . The time taken for such high fitness alleles to arise and establish is expected to be greater than for alleles of moderate fitness. The rarity of high fitness ART-R alleles may explain why the C580Y allele appeared after other alleles, but subsequently swept through the population on the Thai-Myanmar border.
Population mutation parameter and N e estimates
N e is a central measure in population genetic analysis that determines the level of genetic drift or inbreeding in idealized populations (49) , is key to understanding the rate at which adaptive mutations are introduced into populations (3, 4), but is difficult to measure directly. In this case we are interested in understanding short term N e as this is the period in which ART selection is operating (from 1995 onwards)
. N e can be inferred for natural populations by measuring variation in allele frequencies over time (i.e. by quantifying genetic drift). This approach has been used in the parasite population studied on the Thai-Myanmar border, providing average N e estimates of 1965 (14) and in Senegal where N e estimates were <100. We can also infer the likely value of Θ from the numbers of independent adaptive alleles observed in our population sample. This approach to estimation of N e from Θ follows work on Drosophila (6) and HIV (5) and utilizes the fact that Θ=2N e μ (and therefore N e =Θ/2μ). Θ ranges from 5.9 to 3.9 between 2008-14 on the Thai-Myanmar border and comparable calculations from other SE Asian locations provide remarkably similar estimates (Table S3 ). Using estimates of minimum and maximum mutation rate estimates (5.10 x 10 -8 to 1.15 x10 -7 per nucleotide per generation) and target size (87-163 bp), we determined short term N e to be from 88,017 -1,195,628 on the Thai-Myanmar border (Table 1 ). These estimates of N e are 52-705 times greater than previous estimates of N e from the same parasite population based on fluctuation in allele frequencies at 96
SNPs between 2001-10 (14) . These values are also 9-120 times greater than long-term N e estimates (~10,000) in SE Asia based on nucleotide diversity in mtDNA (50) . One caveat is that we may have underestimated the mutational target size (t). To provide a generous upper bound on the target size we can assume that mutations in all 1771 non-synonymous sites within kelch13 can generate resistance alleles. Even with this obvious overestimate of t, N e estimates (N e = 15,479) are still 9-fold greater than variance N e values from the same population.
Two recent papers have challenged the application of classical population genetics models to malaria parasites and other pathogens (51, 52) . Classical population genetics models make Wright-Fisher assumptions that populations are constant in size, have non-overlapping generations, and that each new generation is sampled from gametes produced by the previous generation. In contrast, the malaria parasite lifecycle consists of very large populations ( ≤10 11 ) of asexually dividing blood stage forms ("gametes") within humans, from which small numbers of gametes (≤10) are sampled by mosquitoes to found the following generation. Simulation studies demonstrate that under the malaria lifecycle, the role of genetic drift is amplified relative to the Wright-Fisher model because small numbers of gametes are sampled from infected people, while the role of selection is amplified because there are very large numbers of parasites within patients (52) . Hence, drift-based measures of N e , using fluctuation in allele frequencies, reflect most closely the numbers of parasites passing through the mosquito bottleneck, and provide a gross underestimate of the parasite population relevant for adaptation. We suggest that this decoupling of drift and selection in the malaria lifecycle, may explain the discrepancy between N e estimates, and that the N e relevant for adaptation can best be estimated from Θ. Similar lifecycles are found in multiple pathogens and parasites: more thorough evaluation of the potential bias in applying classical population genetic tools to these organisms is urgently needed. Previous analyses have suggested that the availability of mutations limits drug resistance evolution in Plasmodium (53) . The large N e values inferred here suggest we have underestimated the capacity for adaptive evolution in Plasmodium.
A spectrum of selective events in Plasmodium
Selective events associated with 5 additional loci have been extensively studied in SE Asian parasite populations and reveal a spectrum of sweeps ranging from hard to soft. We use estimates of Θ to better understand this spectrum. Both the chloroquine resistance transporter (crt) and dhfr provide examples of hard selective sweeps in SE Asia. A single allele (K76T) at crt spread through SE Asian malaria populations, purging genetic variation from genomic regions flanking crt, and this allele subsequently also spread across Africa (12) . In the case of dhfr, 2-4 mutations conferring resistance have been observed on the Thai-Myanmar border. However, all of these mutations share the same flanking regions, consistent with a series of hard selective sweeps in which mutations arose successively on the same sweeping haplotype (10) . Resistance at both crt and dhfr involves specific single SNP mutations, so the target size (t) is 1. As a consequence Θ will be reduced ~100-fold relative to kelch13 to ~0.05. In this range of Θ values, multiple coexisting alleles are expected to be rare. Hence, the observation of hard sweeps at dhfr and crt is broadly consistent with and dependent on target size. Resistance alleles at multidrug transporter (mdr1) and GTP cyclohydrolase I (gch1) and dihydropteroate synthase (dhps) loci have multiple independent origins. Both mdr1 and gch1
involve multiple independent origins of resistance-associated copy number variants (CNVs). There are between 5-15 independent origins of resistance-associated CNVs containing mdr1 (54) , and at least three independent origins of CNVs containing gch1 (55) . In this case, the elevated mutation rate of CNV compared with SNPs most likely explains the multiple co-existing alleles. Finally, studies of dhps evolution, which involves five specific amino acid positions, strongly suggest several origins, because microsatellite loci flanking this locus show minimal reduction in variation relative to wild-type alleles and several different haplotypes are associated with resistant dhps alleles (56) (57) (58) .
Implications for resistance evolution and management
Our re-estimation of N e for malaria in SE Asia has important implications for resistance evolution and management. ART combination therapy was introduced on the Thai-Myanmar border in 1995, resistance was first suspected in 2008, and resistance alleles have now almost reached fixation.
When did resistance alleles first become established in this parasite population? The time to establishment (T e ) -when resistance alleles first escape elimination by genetic drift -is: = 1 � (4). Hence, T e is 2.23 generations or 4.66 months (assuming 6 generations/yr) for this parasite population, suggesting that resistance alleles likely became established on the Thai-Myanmar border in the mid-nineties within a year of ART deployment. This is 8 years before resistance alleles were first observed in this longitudinal dataset ( Fig. 1 and 4) , and 13 years before resistance was suspected in SE Asia (17) . The average number of ART-R mutations arising between 1995 and fixation is 2 ( )/ , where = 2 (3). Hence, with our estimated parameters ( Table 1) ART-R mutations will have arisen 716 times in the course of this selective event.
Artemisinin is used to treat patients in combination with other drugs such as lumefantrine, mefloquine and piperaquine. This is expected to constrain resistance evolution, because the probabilities of a parasite gaining mutations against two different drugs is the product of the rate at which mutation generates resistance alleles conferring resistance against each individual drug. This policy appears to have worked poorly in restraining resistance evolution given that ART resistance has evolved multiple times, and ART-R mutations are estimated to have established in treated population <1 year following introduction of ART combinations. The use of partner drugs (e.g. mefloquine and lumefrantine) to which resistance has already emerged is one contributor to the failure of ACTs. Our results suggest that antimalarial combinations will need to contain more than two fully effective drugs to effectively constrain resistance evolution. This conclusion is very similar to that reached by HIV researchers (59).
Resistance breakthroughs occurred rapidly within patients treated with early HIV drug cocktails with multiple origins of resistance occurring within single infections. As HIV drug combinations increased in complexity, drug breakthroughs have became increasingly rare and drug resistance associated sweeps significantly harder (60) . In South East Asia triple combination containing artesunate and mefloquine + piperaquine, or lumefantrine + amodiaquine are now under clinical trials. However, use of triple or quadruple combinations is severely limited by the availability of possible drugs.
The evolution of ART-R demonstrates the importance of mutational target size for resistance evolution. We suggest that target size can readily be incorporated into preliminary evaluations of promising new antimalarial compounds, prior to deployment. Laboratory selection of cultured parasites using new antimalarials is now routinely carried out to evaluate the potential for resistance evolution (61) . Such studies can be used both to identify genes that underlie resistance, but also to determine how many nucleotides can generate resistance phenotype. An exciting approach to target size evaluation might be to use CRISPR/Cas9 approaches with degenerate homology regions to generate a population of mutations across a target gene, and then evaluate what fraction of these mutations responds to drug selection. In essence, this approach increases mutation rate in the target gene to allow thorough evaluation of mutational target size. E252Q  G538V  K438N  N458Y  N537I  P441L  P527H  P574L  P667T  R515K  R561H   C580Y   ##### ---------- 
